The expression of inhibitory molecules, such as CTLA-4, PD-1, LAG-3, Tim-3 and TIGIT, is crucial for the suppressive activity [96], making Tregs suppression via checkpoint inhibition a possible approach to promote an efficient anti-tumor immune response. The gene discussed is HAVCR2; the disease is neoplasm.